Outcome impact of individualized fluid management during spine surgery: a before-after prospective comparison study.

BMC Anesthesiology
Lu CheYu G Huang

Abstract

Individualized fluid management (IFM) has been shown to be useful to improve the postoperative outcome of patients undergoing major abdominal surgery. A limited number of clinical studies have been done in orthopaedic patients and have yielded conflicting results. We designed the present study to investigate the clinical impact of IFM in patients undergoing major spine surgery. This is a before-after study done in 300 patients undergoing posterior spine arthrodesis. Postoperative outcomes were compared between control group implementing standard fluid management (n = 150) and IFM group (n = 150) guided by fluid protocol based on continuous stroke volume monitoring and optimization. The primary outcome measure was the proportion of patients who developed one or more complications within 30 days following surgery. During surgery, patients received on average the same volume of crystalloids (7.4 vs 7.2 ml/kg/h) and colloids (1.6 vs 1.6 ml/kg/h) before and after the implementation of IFM. During 30 days following surgery, the proportion of patients who developed one or more complications was lower in the IFM group (32 vs 48%, p < 0.01). This difference was mainly explained by a significant decrease in post-operative nausea and vomi...Continue Reading

Associated Clinical Trials

References

Nov 14, 2006·British Journal of Anaesthesia·M C Bellamy
Dec 29, 2006·The New England Journal of Medicine·Peter PronovostChristine Goeschel
Jan 16, 2009·The New England Journal of Medicine·Alex B HaynesUNKNOWN Safe Surgery Saves Lives Study Group
Jan 5, 2011·Critical Care Medicine·Jean-Louis Vincent
Jun 1, 2011·Critical Care : the Official Journal of the Critical Care Forum·Maurizio CecconiGiorgio Della Rocca
Jun 28, 2011·Critical Care : the Official Journal of the Critical Care Forum·Lidia DalfinoNicola Brienza
Jan 3, 2012·The Spine Journal : Official Journal of the North American Spine Society·John T StreetCharles G Fisher
Feb 18, 2012·British Journal of Anaesthesia·F Michard, M Biais
Jun 5, 2012·British Journal of Anaesthesia·M Doherty, D J Buggy
Apr 18, 2013·JAMA : the Journal of the American Medical Association·Sunil EappenAtul A Gawande
Oct 16, 2013·Annales Françaises D'anesthèsie Et De Rèanimation·B ValletUNKNOWN Socie´te ´ franc ¸aise d’anesthe´sie et de re´animation
Nov 19, 2013·The Spine Journal : Official Journal of the North American Spine Society·Michael J LeeJens R Chapman
Jul 6, 2014·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Ke PengFu-hai Ji
Oct 29, 2014·Critical Care : the Official Journal of the Critical Care Forum·Jan BenesFrederic Michard
Mar 27, 2015·BMJ Quality & Safety·Margareth Crisóstomo PortelaMary Dixon-Woods
Apr 22, 2015·Perioperative Medicine·Lais Helena Camacho NavarroGeorge C Kramer
May 11, 2018·The New England Journal of Medicine·Paul S MylesUNKNOWN Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Car
Jul 30, 2018·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Maximilian F KasparekJosef Grohs
Aug 4, 2018·Journal of Clinical Monitoring and Computing·Mariana F LimaFrederic Michard
Feb 23, 2019·Anesthesiology·Timothy E Miller, Paul S Myles

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02470221

Software Mentioned

Vigileo
SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.